ZBH Stock Might Rise Following FDA Nod for Knee Implant ComponentZacks Investment Research • 12/05/24
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.PRNewsWire • 11/25/24
ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee SystemZacks Investment Research • 11/20/24
ZBH Stock to Gain Support From Market Share Gains Amid Macro IssuesZacks Investment Research • 11/11/24
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual ForecastsBenzinga • 10/30/24
Countdown to Zimmer (ZBH) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 10/29/24
Zimmer Biomet to Debut New Z1™ Femoral Hip System and Clinical Data on G7® Acetabular System at 2024 AAHKS Annual MeetingPRNewsWire • 10/28/24
Zimmer Biomet (ZBH) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/23/24
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial ResultsPRNewsWire • 10/09/24